Dosing rationale using population pharmacokinetics of sotalol in children with tachycardia

被引：0
|
作者：
Läer, S
Elshoff, JP
Mir, TS
Müller-Wolf, C
Weil, J
Hulpke-Wette, M
Meibohm, B
机构：
[1] Univ Hamburg, Hosp Eppendorf, Inst Expt & Klin Pharmakol, D-20246 Hamburg, Germany
[2] Univ Hamburg, Hosp Eppendorf, Abt Padiat Kardiol, D-20246 Hamburg, Germany
[3] Univ Gottingen, Abt Padiat Kardiol, D-3400 Gottingen, Germany
[4] Univ Tennessee, Ctr Hlth Sci, Dept Pharmaceut Sci, Memphis, TN 38163 USA
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2003年 / 367卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
441
引用
收藏
页码：R114 / R114
页数：1
相关论文
共 50 条
  • [21] Evaluation of Individualized Cefepime Dosing Strategy Using Population Pharmacokinetics
    Mo, Yoonsun
    Shcherbakova, Natalia
    Inman, Kelsey L.
    Li, Wai Kin
    Kovalenko, Kateryna
    Rosenberg, Joshua
    Orsini, Jose
    Truong, James
    JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 62 (03): : 359 - 365
  • [22] Population Pharmacokinetics of Fusidic Acid: Rationale for Front-Loaded Dosing Regimens Due to Autoinhibition of Clearance
    Bulitta, Juergen B.
    Okusanya, Olanrewaju O.
    Forrest, Alan
    Bhavnani, Sujata M.
    Clark, Kay
    Still, J. Gordon
    Fernandes, Prabhavathi
    Ambrose, Paul G.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (01) : 498 - 507
  • [23] Termination of automatic atrial tachycardia in an infant by adequate sotalol dosingIndication of clinically relevant age-dependent pharmacokinetics of sotalol
    S. Läer
    B. Meibohm
    T. Mir
    M. Hulpke-Wette
    European Journal of Clinical Pharmacology, 2001, 57 : 181 - 182
  • [24] Population Pharmacokinetics and Dosing Optimization of Azithromycin in Children with Community-Acquired Pneumonia
    Zheng, Yi
    Liu, Shu-Ping
    Xu, Bao-Ping
    Shi, Zhong-Ren
    Wang, Kai
    Yang, Jin-Bin
    Huang, Xin
    Tang, Bo-Hao
    Chen, Xing-Kai
    Shi, Hai-Yan
    Zhou, Yue
    Wu, Yue-E
    Qi, Hui
    Jacqz-Aigrain, Evelyne
    Shen, A-Dong
    Zhao, Wei
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (09)
  • [25] THE PHARMACOKINETICS OF CEFPIROME - RATIONALE FOR A 12-HOUR DOSING REGIMEN
    CRAIG, WA
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1993, : 33 - 40
  • [26] Developmental changes in proarrhythmic and antiarrhythmic action of sotalol in children with tachycardia
    Laer, S
    Elshoff, JP
    Scholz, H
    Wauer, I
    Meibohm, B
    Mir, TS
    Weil, J
    Hulpke-Wette, M
    CIRCULATION, 2001, 104 (17) : 488 - 489
  • [27] Pharmacokinetics and pharmacodynamics of sotalol in a pediatric population with supraventricular and ventricular tachyarrhythmia
    Saul, JP
    Ross, B
    Schaffer, MS
    Beerman, L
    Melikian, AP
    Shi, J
    Williams, J
    Barbey, JT
    Jin, J
    Hinderling, PH
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (03) : 145 - 157
  • [28] PHARMACOKINETICS OF NADOLOL IN CHILDREN WITH SUPRAVENTRICULAR TACHYCARDIA
    MEHTA, AV
    CHIDAMBARAM, B
    RICE, PJ
    JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 32 (11): : 1023 - 1027
  • [29] Population pharmacokinetics and dosing of dispersible moxifloxacin formulation in children with rifampicin-resistant tuberculosis
    Palmer, Megan
    Zou, Yuanxi
    Hesseling, Anneke C.
    van Der Laan, Louvina
    Courtney, Ingrid
    Kinikar, Aarti A.
    Sonkawade, Naresh
    Paradkar, Mandar
    Kulkarni, Vandana
    Casalme, Dessa Jean O.
    Frias, Melchor V. G.
    Draper, Heather
    Wiesner, Lubbe
    Karlsson, Mats O.
    Denti, Paolo
    Svensson, Elin M.
    Garcia-Prats, Anthony J.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2025,
  • [30] Population pharmacokinetics and dosing optimization of perampanel in children with epilepsy: A real-world study
    Li, Sichan
    Yi, Jiaqin
    Tuo, Yali
    Nie, Gang
    Wang, Jun
    Wang, Yang
    Sun, Dan
    Liu, Zhisheng
    EPILEPSIA, 2024, 65 (06) : 1687 - 1697
12345